AstraZeneca has elected not to move forward with a COVID-19 preventive in the US, despite approvals in other parts of the world, after resistance emerged in a late-stage clinical trial. AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results